Nanoceria: a Potential Therapeutic for Dry AMD.

Abstract

Age-related macular degeneration (AMD) is the leading cause of blinding diseases. The "dry" form of AMD is the most common form of AMD. In contrast to the treatable neovascular (wet) AMD, no effective treatment is available for dry AMD. In this review, we summarize the animal models and therapeutic strategies for dry AMD. The novel candidates as potential treatment targets and the potential effectiveness of nanoceria as a treatment of dry AMD are also discussed.

DOI: 10.1007/978-3-319-17121-0_16

Cite this paper

@article{Cai2016NanoceriaAP, title={Nanoceria: a Potential Therapeutic for Dry AMD.}, author={Xue Yong Cai and James F. McGinnis}, journal={Advances in experimental medicine and biology}, year={2016}, volume={854}, pages={111-8} }